Biotechnology

 

Click the highlighted date for further information.

2018 Conferences

Sept 23-26, 2018 (18AS) SINGLE-USE TECHNOLOGIES III (Snowbird, Utah)
R. Repetto, Pfizer; W. Ding, Amgen; M. Micheletti, UCL

2019 Conferences

Jan 27-31, 2019 (19AT) ADVANCING MANUFACTURE OF CELL AND GENE THERAPIES VI (Coronado, CA)
D.Baksh, GE Healthcare; I. Wall, Aston University ; R. Rietze, Novartis

June 2-6, 2019 (19AO) ADVANCES IN OPTICS FOR BIOTECHNOLOGY, MEDICINE AND SURGERY (Mont Tremblant, Quebec, Canada)
E. Buckley, Emory University; C. Moser, EPFL; B. Pogue, Dartmouth College; D. Sampson, University of Western Australia

July 14-17, 2019 (19AF) BIOLOGICAL AND PHARMACEUTICAL COMPLEX FLUIDS III (Hernstein, Austria)
S. Amin, Manhattan College; Miguel Rodriguez, Univ. of Lisbon; Paolo Arosio (ETHZ, Switzerland)

July 14-18, 2019 (19AM) BIOCHEMICAL AND MOLECULAR ENGINEERING XXI (Mont Tremblant, Canada)
C. Chan, Michigan State University; M. Koffas, RPI; S. Schaffer, Evonik; R. Kshirsagar, Biogen

July 21-24, 2018 (19AG) COLLOIDAL, MACROMOLECULAR AND BIOLOGICAL GELS II(Cork, Ireland)
S. Amin, Manhattan College; S. Khan, North Carolina State University; S.R. Raghavan, University of Maryland

September 8-13, 2019 (19AB) NATURE INSPIRED ENGINEERING (Cetraro (Calabria), Italy)
M.-O. Coppens, University College London; B. Bhushan, Ohio State University

September 15-19, 2019 (19AE) ENZYME ENGINEERING XXV (Whistler, British Columbia, Canada)
H. Zhao, Univ. of Illinois at Urbana-Champaign; J. Wong, Pfizer

 October 6-10, 2019 (19AA) INTEGRATED CONTINUOUS BIOMANUFACTURING IV (Brewster (Cape Cod), Massachusetts, USA)
V. Warikoo, Roche; A. Jungbauer, BOKU; J. Coffman, Boehringer Ingelheim; J. Walther, Sanofi

2020 Conferences

April 19-23, 2020 (20AK) MICROBIAL ENGINEERING II (Albufeira, Portugal)
E. Keshavarz-Moore, University College London; B. Buckland, BiologicB

May 3-7, 2020 (20AD) PHARMACEUTICAL ENGINEERING: The FRONTIER MANUFACTURING OF DRUG API AND DRUG PRODUCTS (Irsee, Germany)
D. Hsieh, Bristol-Myers Squibb co. (retired); G. Aderborn, Uppsala University; C. Adjiman, Imperial College; D. Lyngberg, Janssen Pharmaceuticals, Belgium; S. King, Rutgers University

May TBA 2020 (20AC) CELL CULTURE ENGINEERING XVII (TBA)
T. Charlebois, Pfizer; J.D. Young, Vanderbilt University; G. Maheshwari, Merck

June 14-19, 2020 (20AA) VACCINE TECHNOLOGY VIII (Sitges, Spain)
T. Mukhopadhyay, University College London; C. Lutsch, Sanofi Pasteur; L. Lua, University of Queensland; F. Godia, Universitat Autònoma de Barcelona